Physician profile
Eric S Graham
NPI 1720120462
$14,178.96
in general payments reported to CMS, 2019-2025
38 companies · $2,243 in 2025
The $2,243 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,097 · 2020: $1,503 · 2021: $1,877 · 2022: $1,601 · 2023: $2,379 · 2024: $2,479 · 2025: $2,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,956 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,956.02 |
| Education | $145.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,599.74 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $1,991.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $1,814.85 | 2021-2025 | |
| Amgen INC. | $1,486.01 | 2019-2025 | Otezla, Repatha, Otezla |
| Novo Nordisk INC | $1,002.15 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $851.69 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $590.51 | 2019-2025 | Jardiance, Tradjenta |
| Pfizer INC. | $524.94 | 2019-2024 | |
| Harmony Biosciences LLC | $467.11 | 2023-2025 | Wakix |
| Allergan, INC. | $370.17 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $331.73 | 2024-2025 | Voquezna |
| Abbott Laboratories | $271.68 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2, Freestyle Libre |
| Esperion Therapeutics, INC. | $208.35 | 2020-2021 | |
| Eisai INC. | $167.39 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.10 | 2023-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.